Skip to main content
Clinical Trials/ACTRN12621001143819
ACTRN12621001143819Not yet recruitingPhase 2

A multi-centre, randomised trial of periprostatic nerve block in transperineal prostate biopsy under general anaesthesia in patients with suspected prostate cancer.

Chris O Brien Lifehouse0 sites50 target enrollmentStarted: August 25, 2021Last updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Enrollment
50

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Blinded (masking used)

Eligibility Criteria

Ages
18 Years to o limit (—)
Sex
Male

Inclusion Criteria

  • 1.Patients undergoing transperineal prostate biopsy.
  • 2.Patients who can provide informed consent for participation in this study.

Exclusion Criteria

  • 1.Any patient who cannot provide informed consent or is unwilling to participate in this study.
  • 2.Any patient who has received a locoregional nerve block in the 24 hours prior to transperineal nerve block.
  • 3.Any patient with a history of anaphylaxis following local anaesthetic injection.
  • 4.Any patient unable to communicate, read or write in English to a level where they are able to understand the study and consent to inclusion.

Investigators

Similar Trials

A randomised clinical trial comparing... | Clinical Trial